Inflammation in aging processes: An integrative and ecological perspective

Handbook of the Biology of Aging

Volumn , Issue , 2011, Pages 275-296

  Finch, Caleb E ^a,b  

^a Davis School of Gerontology   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84862819136     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-378638-8.00012-9     Document Type: Chapter

References (238)

1. Abarbanell A.M., Coffey A.C., Fehrenbacher J.W., Beckman D.J., Herrmann J.L., Weil B., et al. Proinflammatory cytokine effects on mesenchymal stem cell therapy for the ischemic heart. Annals of Thoracic Surgery 2009, 88(3):1036-1043.
2. Abreu M.T. Toll-like receptor signalling in the intestinal epithelium: How bacterial recognition shapes intestinal function. Nature Reviews Immunology 2010, 10(2):131-144.
3. Akiyama H., Barger S., Barnum S., Bradt B., Bauer J., Cole G.M., et al. Inflammation and Alzheimer's disease. Neurobiology of Aging 2000, 21(3):383-421.
4. Albala C., Yáñez M., Devoto E., Sostin C., Zeballos L., Santos J.L. Obesity as a protective factor for postmenopausal osteoporosis. International Journal of Obesity and Related Metabolic Disorders 1996, 20(11):1027-1032.
5. Albani D., Polito L., Forloni G. Sirtuins as novel targets for Alzheimer's disease and other neurodegenerative disorders: Experimental and genetic evidence. Journal of Alzheimer's Disease 2010, 19(1):11-26.
6. Anagnostis P., Karagiannis A., Kakafika A.I., Tziomalos K., Athyros V.G., Mikhailidis D.P. Atherosclerosis and osteoporosis: Age-dependent degenerative processes or related entities?. Osteoporosis International 2009, 20(2):197-207.
7. Andres R., Tobin J.D. Endocrine systems. Handbook of the biology of aging 1977, 357-378. Van Nostrand, New York. 1st ed. C.E. Finch, L. Hayflick (Eds.).
8. Araujo J.A., Barajas B., Kleinman M., Wang X., Bennett B.J., Gong K.W., et al. Ambient particulate pollutants in the ultrafine range promote early atherosclerosis and systemic oxidative stress. Circulation Research 2008, 102(5):589-596.
9. Armani C., Landini L., Leone A. Molecular and biochemical changes of the cardiovascular system due to smoking exposure. Current Pharmaceutical Design 2009, 15(10):1038-1053.
10. Asghar M., George L., Lokhandwala M.F. Exercise decreases oxidative stress and inflammation and restores renal dopamine D1 receptor function in old rats. American Journal of Physiology: Renal Physiology. 2007, 293(3):F914-F919.
11. Atzmon G., Rincon M., Schechter C.B., Shuldiner A.R., Lipton R.B., Bergman A., et al. Lipoprotein genotype and conserved pathway for exceptional longevity in humans. PLoS Biology 2006, 4(4):e113.
12. Axmann R., Böhm C., Krönke G., Zwerina J., Smolen J., Schett G. Inhibition of interleukin-6 receptor directly blocks osteoclast formation in vitro and in vivo. Arthritis & Rheumatology 2009, 60(9):2747-2756.
13. BanfiG., Iorio E.L., Corsi M.M. Oxidative stress, free radicals and bone remodeling. Clinical Chemistry and Laboratory Medicine 2008, 46(11):1550-1555.
14. Baker L.D., Frank L.L., Foster-Schubert K., Green P.S., Wilkinson C.W., McTiernan A., et al. Effects of aerobic exercise on mild cognitive impairment: A controlled trial. Archives of Neurology 2010, 67(1):71-79.
15. Barker D.J.P. Mothers, babies and disease in later life. 1998, Churchill Livingstone, Edinburgh.
16. Bauer A.K., Fostel J., DegraffL.M., Rondini E.A., Walker C., Grissom S.F., et al. Transcriptomic analysis of pathways regulated by toll-like receptor 4 in a murine model of chronic pulmonary inflammation and carcinogenesis. Molecular Cancer 2009, 8:107.
17. Bentz G.L., Yurochko A.D. Human CMV infection of endothelial cells induces an angiogenic response through viral binding to EGF receptor and beta1 and beta3 integrins. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:5531-5536.
18. Bhaumik D., Scott G.K., Schokrpur S., Patil C.K., Orjalo A.V., Rodier F., et al. MicroRNAs miR-146a/b negatively modulate the senescence-associated inflammatory mediators IL-6 and IL-8. Aging 2009, 1(4):402.
19. Block M.L., Calderón-Garcidueñas L. Air pollution: Mechanisms of neuroinflammation and CNS disease. Trends in Neurosciences 2009, 32(9):506-516.
20. Bråkenhielm E., Cao R., Cao Y. Suppression of angiogenesis, tumor growth, and wound healing by resveratrol, a natural compound in red wine and grapes. Journal of the Federation of American Societies for Experimental Biology 2001, 15(10):1798-1800.
21. Bruunsgaard H. Physical activity and modulation of systemic low-level inflammation. Journal of Leukocyte Biology 2005, 78(4):819-835.
22. Butcher S.K., Chahal H., Nayak L., Sinclair A., Henriquez N.V., Sapey E., et al. Senescence in innate immune responses: Reduced neutrophil phagocytic capacity and CD16 expression in elderly humans. Journal of Leukocyte Biology 2001, 70(6):881-886.
23. Cai W., He J.C., Zhu L., Chen X., Striker G.E., Vlassara H. AGE-receptor-1 counteracts cellular oxidant stress induced by AGEs via negative regulation of p66shc-dependent FKHRL1 phosphorylation. American Journal of Physiology and Cell Physiology 2008, 294(1):C145-C152.
24. Cai W., He J.C., Zhu L., Chen X., Zheng F., Striker G.E., et al. Oral glycotoxins determine the effects of calorie restriction on oxidant stress, age-related diseases, and lifespan. American Journal of Pathology 2008, 173(2):327-336.
25. Calderón-Garcidueñas L., Solt A.C., Henríquez-Roldán C., Torres-Jardón R., Nuse B., Herritt L., et al. Long-term air pollution exposure is associated with neuroinflammation, an altered innate immune response, disruption of the blood-brain barrier, ultrafine particulate deposition, and accumulation of amyloid beta-42 and alpha-synuclein in children and young adults. Toxicologic Pathology 2008, 36(2):289-310.
26. Capurso C., Solfrizzi V., D'Introno A., Colacicco A.M., Capurso S.A., Semeraro C., et al. Interleukin 6 variable number of tandem repeats (VNTR) gene polymorphism in centenarians. Annals of Human Genetics 2007, 71(Pt. 6):843-848.
27. Castelli W.P. Lipids, risk factors and ischaemic heart disease. Atherosclerosis 1996, 124:S1-S9.
28. Cerami A., Vlassara H., Brownlee M. Glucose and aging. Scientific American 1987, 256(5):90-96.
29. Chen J., Zhou Y., Mueller-Steiner S., Chen L.F., Kwon H., Yi S., et al. SIRT1 protects against microglia-dependent amyloid-beta toxicity through inhibiting NF-kappaB signaling. Journal of Biological Chemistry 2005, 280(48):40364-40374.
30. Chen J.R., Shankar K., Nagarajan S., Badger T.M., Ronis M.J. Protective effects of estradiol on ethanol-induced bone loss involve inhibition of reactive oxygen species generation in osteoblasts and downstream activation of the extracellular signal-regulated kinase/signal transducer and activator of transcription 3/receptor activator of nuclear factor-kappaB ligand signaling cascade. Journal of Pharmacology and Experimental Therapeutics 2008, 324(1):50-59.
31. Chen X., Striker G.E., Vlassara H. AGE-receptor-1 counteracts cellular oxidant stress induced by AGEs via negative regulation of p66shc-dependent FKHRL1 phosphorylation. American Journal of Physiology: Cell Physiology 2008, 294(1):C145-C152.
32. Cho Y.I., Mooney M.P., Cho D.J. Hemorheological disorders in diabetes mellitus. Journal of Diabetes Science and Technology 2008, 2(6):1130-1138.
33. Choi Y.H., Kim J.H., Kim D.K., Kim J.W., Kim D.K., Lee M.S., et al. Distributions of ACE and APOE polymorphisms and their relations with dementia status in Korean centenarians. Journals of Gerontology, Series A, Biological Sciences and Medical Sciences 2003, 58(3):227-231.
34. Chou M.Y., Hartvigsen K., Hansen L.F., Fogelstrand L., Shaw P.X., Boullier A., et al. Oxidation-specific epitopes are important targets of innate immunity. Journal of Internal Medicine 2008, 263(5):479-488.
35. Chung H.Y., Cesari M., Anton S., Marzetti E., Giovannini S., Seo A.Y., et al. Molecular inflammation: Underpinnings of aging and age-related diseases. Ageing Research Reviews 2009, 8(1):18-30.
36. Cole S.L., Vassar R. Linking vascular disorders and Alzheimer's disease: Potential involvement of BACE1. Neurobiology of Aging 2009, 30(10):1535-1544.
37. Coppé J.P., Patil C.K., Rodier F., Krtolica A., Beauséjour C.M., Parrinello S., et al. A human-like senescence-associated secretory phenotype is conserved in mouse cells dependent on physiological oxygen. PLoS ONE 2010, 5(2):e9188.
38. Coppé J.P., Patil C.K., Rodier F., Sun Y., Muñoz D.P., Goldstein J., et al. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biology 2008, 6(12):2853-2868.
39. Crimmins E.M., Finch C.E. Infection, inflammation, height, and longevity. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:498-503.
40. Crimmins E.M., Vasunilashorn S., Kim J.K., Alley D. Biomarkers related to aging in human populations. Advances in Clinical Chemistry 2008, 46:161-215.
41. Csiszar A., Labinskyy N., Jimenez R., Pinto J.T., Ballabh P., Losonczy G., et al. Anti-oxidative and anti-inflammatory vasoprotective effects of caloric restriction in aging: Role of circulating factors and SIRT1. Mechanisms of Ageing and Development 2009, 130(8):518-527.
42. Danesh J., Kaptoge S., Mann A.G., Sarwar N., Wood A., Angleman S.B., et al. Long-term interleukin-6 levels and subsequent risk of coronary heart disease: Two new prospective studies and a systematic review. PLoS Medicine 2008, 5(4):e78.
43. D'Armiento F.P., Bianchi A., de Nigris F., Capuzzi D.M., D'Armiento M.R., Crimi G., et al. Age-related effects on atherogenesis and scavenger enzymes of intracranial and extracranial arteries in men without classic risk factors for atherosclerosis. Stroke 2001, 32:2472-2479.
44. Dato S., Carotenuto L., De Benedictus G. Genes and longevity: A genetic-demographic approach reveals sex- and age-specific gene effects not shown by the case-control approach (APOE and HSP70.1 loci). Biogerontology 2007, 8(1):31-41.
45. Dato S., Krabbe K.S., Thinggaard M., Pedersen B.K., Christensen K., Bruunsgaard H., et al. Commonly studied polymorphisms in inflammatory cytokine genes show only minor effects on mortality and related risk factors in nonagenarians. Journals of Gerontology, Series A, Biological Science and Medical Science 2010, 65(3):225-235.
46. Daun S., Rubin J., Vodovotz Y., Roy A., Parker R., Clermont G. An ensemble of models of the acute inflammatory response to bacterial lipopolysaccharide in rats: Results from parameter space reduction. Journal of Theoretical Biology 2008, 253(4):843-853.
47. Davidson-Moncada J., Papavasiliou F.N., Tam W. MicroRNAs of the immune system: Roles in inflammation and cancer. Annals of the New York Academy of Sciences 2010, 1183:183-194.
48. Ding C., Parameswaran V., Udayan R., Burgess J., Jones G. Circulating levels of inflammatory markers predict change in bone mineral density and resorption in older adults: A longitudinal study. Journal of Clinical Endocrinology and Metabolism 2008, 93(5):1952-1958.
49. Drabe N., Zünd G., Grünenfelder J., Sprenger M., Hoerstrup S.P., Bestmann L., et al. Genetic predisposition in patients undergoing cardiopulmonary bypass surgery is associated with an increase of inflammatory cytokines. European Journal of Cardio-Thoracic Surgery 2001, 20(3):609-613.
50. Edo M.D., Andrés V. Aging, telomeres, and atherosclerosis. Cardiovascular Research 2005, 66(2):213-221.
51. Elder A.C., Gelein R., Azadniv M., Frampton M., Finkelstein J., Oberdörster G. Systemic effects of inhaled ultrafine particles in two compromised, aged rat strains. Inhalation Toxicology 2004, 16(6-7):461-471.
52. Elliot A.J., Fleming D.M. Influenza and respiratory syncytial virus in the elderly. Expert Review of Vaccines 2008, 7(2):249-258.
53. Enzler T., Gillessen S., Manis J.P., Ferguson D., Fleming J., Alt F.W., et al. Deficiencies of GM-CSF and interferon gamma link inflammation and cancer. Journal of Experimental Medicine 2003, 197(9):1213-1219.
54. Ewbank D.C. The APOE gene and differences in life expectancy in Europe. Journals of Gerontology, Series A, Biological Sciences and Medical Sciences 2004, 59(1):16-20.
55. Fabris C., Toniutto P., Bitetto D., Minisini R., Smirne C., Caldato M., et al. Low fibrosis progression of recurrent hepatitis C in apolipoprotein E epsilon4 carriers: Relationship with the blood lipid profile. Liver International 2005, 25(6):1128-1135.
56. Fabris N., Mocchegiani E., Muzzioli M., Provinciali M. Neuroendocrine-thymus interactions: Perspectives for intervention in aging. Annals of the New York Academy of Sciences 1988, 521:72-87.
57. Farinati F., Cardin R., Cassaro M., Bortolami M., Nitti D., Tieppo C., et al. Helicobacter pylori, inflammation, oxidative damage and gastric cancer: A morphological, biological and molecular pathway. European Journal of Cancer Prevention 2008, 17(3):195-200.
58. Ferrucci L., Corsi A., Lauretani F., Bandinelli S., Bartali B., Taub D.D., et al. The origins of age-related proinflammatory state. Blood 2005, 105(6):2294-2299.
59. Finch C.E. Comparative biology of senescence: Evolutionary and developmental considerations. Animal models for biomedical research IV (pp. 47-67) 1972, National Academy of Sciences, Washington, DC, (pp. 47-67).
60. Finch C.E. Developmental origins of aging in brain and blood vessels: An overview. Neurobiology of Aging 2005, 26(3):281-291.
61. Finch C.E. The biology of human longevity: Inflammation, nutrition, and aging in the evolution of lifespans 2007, Academic Press, San Diego.
62. Finch C.E. The evolution of the human lifespan and diseases of aging: Roles of infection, inflammation, and nutrition. Proceedings of the National Academy of Sciences of the United States of America 2010, 107(Suppl. 1):1718-1724.
63. Finch C.E., Crimmins E.M. Inflammatory exposure and historical changes in human life spans. Science 2004, 305(5691):1736-1739.
64. Finch C.E., Crimmins E.M. Response to comment on "Inflammatory exposure and historical changes in human life spans.". Science 2005, 308:1743.
65. Finch C.E., Kirkwood T.B.L. Chance, development, and aging 2000, Oxford University Press, New York.
66. Finch C.E., Sapolsky R.M. The evolution of Alzheimer disease, the reproductive schedule, and apoE isoforms. Neurobiology of Aging 1999, 20(4):407-428.
67. Finch C.E., Stanford C.B. Meat adaptive genes and the evolution of slower aging in humans. Quarterly Review of Biology 2004, 79(1):3-50.
68. Finch C.E., Tanzi R.E. Genetics of aging. Science 1997, 278(5337):407-411.
69. Finot P.A. Historical perspective of the Maillard reaction in food science. Annals of the New York Academy of Science 2005, 1043:1-8.
70. Flachsbart F., Caliebe A., Kleindorp R., Blanché H., von Eller-Eberstein H., Nikolaus S., et al. Association of FOXO3A variation with human longevity confirmed in German centenarians. Proceedings of the National Academy of Sciences of the United States of America 2009, 106(8):2700-2705.
71. + T cells in healthy carriers are continuously driven to replicative exhaustion. Journal of Immunology 2005, 175(12):8218-8225.
72. Fogel R.W., Costa D.L. A theory of technophysio evolution, with some implications for forecasting population, health care costs, and pension costs. Demography 1997, 34(1):49-66.
73. Fontana L., Eagon J.C., Trujillo M.E., Scherer P.E., Klein S. Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes 2007, 56(4):1010-1013.
74. Ford D., Tower J. Genetic manipulation of life span in Drosophila melanogaster. Handbook of the biology of aging 2006, 400-414. Academic Press, San Diego. 6th ed. E.J. Masaro, S.N. Austad (Eds.).
75. Forster M.J., Sohal B.H., Sohal R.S. Reversible effects of long-term caloric restriction on protein oxidative damage. Journals of Gerontology, Series A, Biological Sciences and Medical Sciences 2000, 55(11):B522-B529.
76. Franceschi C., Capri M., Monti D., Giunta S., Olivieri F., Sevini F., et al. Inflammaging and anti-inflammaging: A systemic perspective on aging and longevity emerged from studies in humans. Mechanisms of Ageing and Development 2007, 128(1):92-105.
77. Galic S., Oakhill J.S., Steinberg G.R. Adipose tissue as an endocrine organ. Molecular and Cellular Endocrinology 2009, 129-139.
78. Galkina E., Ley K. Immune and inflammatory mechanisms of atherosclerosis. Annual Review of Immunology 2009, 27:165-197.
79. Gao L., Mann G.E. Vascular NAD(P)H oxidase activation in diabetes: A double-edged sword in redox signalling. Cardiovascular Research 2009, 82(1):9-20.
80. Gardy J.L., Lynn D.J., Brinkman F.S., Hancock R.E. Enabling a systems biology approach to immunology: Focus on innate immunity. Trends in Immunology 2009, 30(6):249-262.
81. Garigan D., Hsu A.L., Fraser A.G., Kamath R.S., Ahringer J., Kenyon C. Genetic analysis of tissue aging in Caenorhabditis elegans: A role for heat-shock factor and bacterial proliferation. Genetics 2002, 161(3):1101-1112.
82. Garsin D.A., Villanueva J.M., Begun J., Kim D.H., Sifri C.D., Calderwood S.B., et al. Long-lived C. elegans daf-2 mutants are resistant to bacterial pathogens. Science 2003, 300(5627):1921.
83. Ghoshal S., Witta J., Zhong J., de Villiers W., Eckhardt E. Chylomicrons promote intestinal absorption of lipopolysaccharides. Journal of Lipid Research 2009, 50(1):90-97.
84. Goldman N., Turra C.M., Glei D.A., Seplaki C.L., Lin Y.H., Weinstein M. Predicting mortality from clinical and nonclinical biomarkers. Journals of Gerontology, Series A, Biological Sciences and Medical Sciences 2006, 61(10):1070-1074.
85. Gomez C.R., Acuña-Castillo C., Pérez C., Leiva-Salcedo E., Riquelme D.M., Ordenes G., et al. Diminished acute phase response and increased hepatic inflammation of aged rats in response to intraperitoneal injection of lipopolysaccharide. Journals of Gerontology, Series A, Biological Sciences and Medical Sciences 2008, 63(12):1299-1306.
86. Graham L.S., Parhami F., Tintut Y., Kitchen C.M., Demer L.L., Effros R.B. Oxidized lipids enhance RANKL production by T lymphocytes: Implications for lipid-induced bone loss. Clinical Immunology 2009, 133(2):265-275.
87. Gress R.E., Deeks S.G. Reduced thymus activity and infection prematurely age the immune system. Journal of Clinical Investigation 2009, 119(10):2884-2887.
88. Groeneweg M., Kanters E., Vergouwe M.N., Duerink H., Kraal G., Hofker M.H., et al. Lipopolysaccharide-induced gene expression in murine macrophages is enhanced by prior exposure to oxLDL. Journal of Lipid Research 2006, 47(10):2259-2267.
89. Grossin N., Wautier M.P., Wautier J.L. Red blood cell adhesion in diabetes mellitus is mediated by advanced glycation end product receptor and is modulated by nitric oxide. Biorheology 2009, 46(1):63-72.
90. Grünenfelder J., Umbehr M., Plass A., Bestmann L., Maly F.E., Zünd G., et al. Genetic polymorphisms of apolipoprotein E4 and tumor necrosis factor beta as predisposing factors for increased inflammatory cytokines after cardiopulmonary bypass. Journal of Thoracic and Cardiovascular Surgery 2004, 128(1):92-97.
91. Gruver A.L., Hudson L.L., Sempowski G.D. Immunosenescence of ageing. Journal of Pathology 2007, 211(2):144-156.
92. Gunes T., Koklu E., Yikilmaz A., Ozturk M.A., Akcakus M., Kurtoglu S., et al. Influence of maternal smoking on neonatal aortic intima-media thickness, serum IGF-I and IGFBP-3 levels. European Journal of Pediatrics 2007, 166(10):1039-1044.
93. Guo F., Liu J., Wang C., Liu N., Lu P. Fibrinogen, fibrin, and FDP induce C-reactive protein generation in rat vascular smooth muscle cells: Pro-inflammatory effect on atherosclerosis. Biochemical and Biophysical Research Communications 2009, 390(3):942-946.
94. Guo Z., Mitchell-Raymundo F., Yang H., Ikeno Y., Nelson J., Diaz V., et al. Dietary restriction reduces atherosclerosis and oxidative stress in the aorta of apolipoprotein E-deficient mice. Mechanisms in Ageing and Development 2002, 123(8):1121-1131.
95. Haffner S.M., Bauer R.L. Excess androgenicity only partially explains the relationship between obesity and bone density in premenopausal women. International Journal of Obesity and Related Metabolic Disorders 1992, 16(11):869-874.
96. Hage F.G., Szalai A.J. C-reactive protein gene polymorphisms, C-reactive protein blood levels, and cardiovascular disease risk. Journal of the American College of Cardiology 2007, 50(12):1115-1122.
97. Henderson S.T., Rea S.L., Johnson T.J. Dissecting the processes of aging using the nematode Caenorhabditis elegans. Handbook of the biology of aging 2006, 360-399. Academic Press, San Diego. 6th ed. E.J. Masaro, S.N. Austad (Eds.).
98. Herold K., Moser B., Chen Y., Zeng S., Yan S.F., Ramasamy R., et al. Receptor for advanced glycation end products (RAGE) in a dash to the rescue: Inflammatory signals gone awry in the primal response to stress. Journal of Leukocyte Biology 2007, 82(2):204-212.
99. Herrmann J.L., Markel T.A., Abarbanell A.M., Weil B.R., Wang M., Wang Y., et al. Proinflammatory stem cell signaling in cardiac ischemia. Antioxidants and Redox Signaling 2009, 11(8):1883-1896.
100. Hevener A.L., Febbraio M.A., the Stock Conference Working Group The 2009 Stock Conference report: Inflammation, obesity and metabolic disease. Obesity Reviews 2010.
101. Hjelmborg J.v. B., Iachine I., Skytthe A., Vaupel J.W., McGue M., Koskenvuo M., et al. Genetic influence on human lifespan and longevity. Human Genetics 2006, 119(3):312-321.
102. Hsieh E.A., Chai C.M., Hellerstein M.K. Effects of caloric restriction on cell proliferation in several tissues in mice: Role of intermittent feeding. American Journal of Physiology: Endocrinology and Metabolism 2005, 288(5):E965-E972.
103. Inoue W., Somay G., Poole S., Luheshi G.N. Immune-to-brain signaling and central prostaglandin E2 synthesis in fasted rats with altered lipopolysaccharide-induced fever. American Journal of Physiology: Regulatory, Integrative and Comparative Physiology 2008, 295(1):R133-R143.
104. Issuree P.D., Pushparaj P.N., Pervaiz S., Melendez A.J. Resveratrol attenuates C5a-induced inflammatory responses in vitro and in vivo by inhibiting phospholipase D and sphingosine kinase activities. Journal of the Federation of American Societies for Experimental Biology 2009, 23(8):2412-2424.
105. James M.L., Sullivan P.M., Lascola C.D., Vitek M.P., Laskowitz D.T. Pharmacogenomic effects of apolipoprotein E on intracerebral hemorrhage. Stroke 2009, 40(2):632-639.
106. Jerrett M., Burnett R.T., Ma R., Pope C.A., Krewski D., Newbold K.B., et al. Spatial analysis of air pollution and mortality in Los Angeles. Epidemiology 2005, 16(6):727-736.
107. Jung K.J., Lee E.K., Yu B.P., Chung H.Y. Significance of protein tyrosine kinase/protein tyrosine phosphatase balance in the regulation of NF-κB signaling in the inflammatory process and aging. Free Radical Biology & Medicine 2009, 47(7):983-991.
108. Kallio K., Jokinen E., Hämäläinen M., Saarinen M., Volanen I., Kaitosaari T., et al. Decreased aortic elasticity in healthy 11-year-old children exposed to tobacco smoke. Pediatrics 2009, 123(2):e267-e273.
109. Karalis K.P., Giannogonas P., Kodela E., Koutmani Y., Zoumakis M., Teli T. Mechanisms of obesity and related pathology: Linking immune responses to metabolic stress. FEBS Journal 2009, 276(20):5747-5754.
110. Karuppagounder S.S., Pinto J.T., Xu H., Chen H.L., Beal M.F., Gibson G.E. Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer's disease. Neurochemistry International 2009, 54(2):111-118.
111. Khaodhiar L., Ling P.R., Blackburn G.L., Bistrian B.R. Serum levels of interleukin-6 and C-reactive protein correlate with body mass index across the broad range of obesity. Journal of Parenteral & Enteral Nutrition 2004, 28(6):410-415.
112. Klebanov S., Diais S., Stavinoha W.B., Suh Y., Nelson J.F. Hyperadrenocorticism, attenuated inflammation, and the life-prolonging action of food restriction in mice. Journals of Gerontology, Series A, Biological Sciences and Medical Sciences 1995, 50(2):B79-B82.
113. Ko G.T., Chan J.C., Woo J., Lau E., Yeung V.T., Chow C.C., et al. Glycated haemoglobin and cardiovascular risk factors in Chinese subjects with normal glucose tolerance. Diabetic Medicine 1998, 15(7):573-578.
114. Kolodgie F.D., Gold H.K., Burke A.P., Fowler D.R., Kruth H.S., Weber D.K., et al. Intraplaque hemorrhage and progression of coronary atheroma. New England Journal of Medicine 2003, 349(24):2316-2325.
115. Korner J., Woods S.C., Woodworth K.A. Regulation of energy homeostasis and health consequences in obesity. American Journal of Medicine 2009, 122(4, Suppl. 1):S12-S18.
116. Kuniyasu H., Kitadai Y., Mieno H., Yasui W. Helicobacter pylori infection is closely associated with telomere reduction in gastric mucosa. Oncology 2003, 65(3):275-282.
117. Künzli N., Jerrett M., Garcia-Esteban R., Basagaña X., Beckermann B., Gilliland F., et al. Ambient air pollution and the progression of atherosclerosis in adults. PLoS ONE 2010, 5(2):e9096.
118. Kurz C.L., Tan M.W. Regulation of aging and innate immunity in C. elegans. Aging Cell 2004, 3(4):185-193.
119. Lai K.N., Leung J.C., Chan L.Y., Li F.F., Tang S.C., Lam M.F., et al. Differential expression of receptors for advanced glycation end-products in peritoneal mesothelial cells exposed to glucose degradation products. Clinical and Experimental Immunology 2004, 138(3):466-475.
120. Lakatta E.G., Wang M., Najjar S.S. Arterial aging and subclinical arterial disease are fundamentally intertwined at macroscopic and molecular levels. Medical Clinics of North America 2009, 93(3):583-604.
121. Landis G.N., Abdueva D., Skvortsov D., Yang J., Rabin B.E., Carrick J., et al. Similar gene expression patterns characterize aging and oxidative stress in Drosophila melanogaster. Proceedings of the National Academy of Sciences of the United States of America 2004, 101(20):7663-7668.
122. Langheinrich A.C., Bohle R.M. Atherosclerosis: Humoral and cellular factors of inflammation. Virchows Archive 2005, 446(2):101-111.
123. Lavie C.J., Milani R.V., Artham S.M., Patel D.A., Ventura H.O. The obesity paradox, weight loss, and coronary disease. American Journal of Medicine 2009, 122(12):1106-1114.
124. Lazennec G., Richmond A. Chemokines and chemokine receptors: New insights into cancer-related inflammation. Trends in Molecular Medicine 2010.
125. Lee A.T., Cerami A. Modification of proteins and nucleic acids by reducing sugars: Possible role in aging. Handbook of the biology of aging 1990, 116-130. Academic Press, San Diego. 3rd ed. E.L. Schneider, J.W. Rowe (Eds.).
126. Lee D.E., Kehlenbrink S., Lee H., Hawkins M., Yudkin J.S. Getting the message across: Mechanisms of physiological cross talk by adipose tissue. American Journal of Physiology: Endocrinology and Metabolism 2009, 296(6):E1210-E1229.
127. Lee M., Aronne L.J. Weight management for type 2 diabetes mellitus: Global cardiovascular risk reduction. American Journal of Cardiology 2007, 99(4A):68B-79B.
128. Lescai F., Marchegiani F., Franceschi C. PON1 is a longevity gene: Results of a meta-analysis. Ageing Research Reviews 2009, 8(4):277-284.
129. Liang R., Bates D.J., Wang E. Epigenetic control of microRNA expression and aging. Current Genomics 2009, 10(3):184-193.
130. Liao C.Y., Rikke B.A., Johnson T.E., Diaz V., Nelson J.F. Genetic variation in the murine lifespan response to dietary restriction: From life extension to life shortening. Aging Cell 2010, 9(1):92-95.
131. Libert S., Chao Y., Chu X., Pletcher S.D. Trade-offs between longevity and pathogen resistance in Drosophila melanogaster are mediated by NFkappaB signaling. Aging Cell 2006, 5(6):533-543.
132. Libert S., Chao Y., Zwiener J., Pletcher S.D. Realized immune response is enhanced in long-lived puc and chico mutants but is unaffected by dietary restriction. Molecular Immunology 2008, 45(3):810-817.
133. Lin L., Park S., Lakatta E.G. RAGE signaling in inflammation and arterial aging. Frontiers in Bioscience 2009, 14:1403-1413.
134. Lio D., Scola L., Crivello A., Colonna-Romano G., Candore G., Bonafè M., et al. Gender-specific association between -1082 IL-10 promoter polymorphism and longevity. Genes and Immunity 2002, 3(1):30-33.
135. Little R.R., Sacks D.B. HbA1c: How do we measure it and what does it mean?. Current Opinion in Endocrinology, Diabetes, and Obesity 2009, 16(2):113-118.
136. Longo V.D., Finch C.E. Evolutionary medicine: From dwarf model systems to healthy centenarians?. Science 2003, 299(5611):1342-1346.
137. Lord J.M., Butcher S., Killampali V., Lascelles D., Salmon M. Neutrophil ageing and immunesenescence. Mechanisms of Ageing and Development 2001, 122(14):1521-1535.
138. Luc G., Bard J.M., Juhan-Vague I., Ferrieres J., Evans A., Amouyel P., Prospective Cohort Study on Myocardial Infarction Study Group, et al. C-reactive protein, interleukin-6, and fibrinogen as predictors of coronary heart disease: The PRIME study. Arteriosclerosis, Thrombosis, and Vascular Biology 2003, 23(7):1255-1261.
139. Madjid M., Willerson J.T., Casscells S.W. Intracoronary thermography for detection of high-risk vulnerable plaques. Journal of the American College of Cardiology 2006, 47(Suppl. 8):C80-C85.
140. Mahley R.W., Huang Y. Alzheimer disease: Multiple causes, multiple effects of apolipoprotein E4, and multiple therapeutic approaches. Annals of Neurology 2009, 65(6):623-625.
141. Mahley R.W., Huang Y., Weisgraber K.H. Detrimental effects of apolipoprotein E4: Potential therapeutic targets in Alzheimer's disease. Current Alzheimer Research 2007, 4(5):537-540.
142. Majno G. The healing hand: Man and wound in the ancient world 1975, Harvard University Press, Cambridge, MA.
143. Mardon J., Habauzit V., Trzeciakiewicz A., Davicco M.J., Lebecque P., Mercier S., et al. Influence of high and low protein intakes on age-related bone loss in rats submitted to adequate or restricted energy conditions. Calcified Tissue International 2008, 82(5):373-382.
144. Martin K., Kirkwood T.B.L. Age changes in stem cells of murine small intestinal crypts. Experimental Cell Research 1998, 241:316-323.
145. Marzetti E., Wohlgemuth S.E., Anton S.D., Bernabei R., Carter C.S., Leeuwenburgh C. Cellular mechanisms of cardioprotection by calorie restriction: State of the science and future perspectives. Clinics in Geriatric Medicine 2009, 25(4):715-732.
146. Mathieu P., Battista D., Depino A., Roca V., Graciarena M., Pitossi F. The more you have, the less you get: The functional role of inflammation on neuronal differentiation of endogenous and transplanted neural stem cells in the adult brain. Journal of Neurochemistry 2010.
147. Mathur N., Pedersen B.K. Exercise as a mean to control low-grade systemic inflammation. Mediators of Inflammation 2008 2008.
148. Maury E., Brichard S.M. Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Molecular and Cellular Endocrinology 2010, 314(1):1-16.
149. Mazumder B., Almond D., Park K., Crimmins E.M., Finch C.E. Lingering prenatal effects of the 1918 influenza pandemic on cardiovascular disease. Journal of Developmental Origins of Health and Disease 2010, 1(1):26-34.
150. McElhaney J.E., Effros R.B. Immunosenescence: What does it mean to health outcomes in older adults?. Current Opinion in Immunology 2009, 21(4):418-424.
151. McGuinness B., Craig D., Bullock R., Passmore P. Statins for the prevention of dementia. Cochrane Database Systematic Reviews 2009, 2:CD003160.
152. McLean R.R. Proinflammatory cytokines and osteoporosis. Current Osteoporosis Reports 2009, 7(4):134-139.
153. Mills C.D., Kincaid K., Alt J.M., Heilman M.J., Hill A.M. M-1/M-2 macrophages and the Th1/Th2 paradigm. Journal of Immunology 2000, 164(12):6166-6673.
154. Minamino T., Orimo M., Shimizu I., Kunieda T., Yokoyama M., Ito T., et al. A crucial role for adipose tissue p53 in the regulation of insulin resistance. Nature Medicine 2009, 15(9):1082-1087.
155. Morgan T.E., Xie Z., Goldsmith S., Yoshida T., Lanzrein A.S., Stone D., et al. The mosaic of brain glial hyperactivity during normal ageing and its attenuation by food restriction. Neuroscience 1999, 89(3):687-699.
156. Mullin J.M., Valenzano M.C., Verrecchio J.J., Kothari R. Age- and diet-related increase in transepithelial colon permeability of Fischer 344 rats. Digestive Diseases & Sciences 2002, 47:2262-2270.
157. Mundy G.R. Osteoporosis and inflammation. Nutrition Reviews 2007, 65(12, Pt. 2):S147-S151.
158. Nakashima Y., Kiyohara Y., Doi Y., Kubo M., Iida M., Sueishi K. Risk factors for coronary atherosclerosis in a general Japanese population: The Hisayama study. Pathology, Research and Practice 2009, 205(10):700-708.
159. Nursten H. The Maillard reaction. Chemistry, biochemistry, and implications 2005, Royal Society of Chemistry, Cambridge UK.
160. O'Connor P.M., Lapointe T.K., Beck P.L., Buret A.G. Mechanisms by which inflammation may increase intestinal cancer risk in inflammatory bowel disease. Inflammatory Bowel Diseases 2010.
161. Ogunleye A.A., Ogston S.A., Morris A.D., Evans J.M. A cohort study of the risk of cancer associated with type 2 diabetes. British Journal of Cancer 2009, 101(7):1199-1201.
162. Panda A., Arjona A., Sapey E., Bai F., Fikrig E., Montgomery R.R., et al. Human innate immunosenescence: Causes and consequences for immunity in old age. Trends in Immunology 2009, 30(7):325-333.
163. Pani L.N., Korenda L., Meigs J.B., Driver C., Chamany S., Fox C.S., et al. Effect of aging on A1C levels in individuals without diabetes: Evidence from the Framingham Offspring Study and the National Health and Nutrition Examination Survey 2001-2004. Diabetes Care 2008, 31(10):1991-1996.
164. Papaioannou A., Kennedy C.C., Cranney A., Hawker G., Brown J.P., Kaiser S.M., et al. Risk factors for low BMD in healthy men age 50 years or older: A systematic review. Osteoporosis International 2009, 20(4):507-518.
165. Park S.K., Kim K., Page G.P., Allison D.B., Weindruch R., Prolla T.A. Gene expression profiling of aging in multiple mouse strains: Identification of aging biomarkers and impact of dietary antioxidants. Aging Cell 2009, 8(4):484-495.
166. Passos J.F., Nelson G., Wang C., Richter T., Simillion C., Proctor C.J., et al. Feedback between p21 and reactive oxygen production is necessary for cell senescence. Molecular Systems Biology 2010, 6:347.
167. Patel N.V., Finch C.E. The glucocorticoid paradox of caloric restriction in slowing brain aging. Neurobiology of Aging 2002, 23(5):707-717.
168. Patel N.V., Gordon M.N., Connor K.E., Good R.A., Engelman R.W., Mason J., et al. Caloric restriction attenuates Abeta-deposition in Alzheimer transgenic models. Neurobiology of Aging 2005, 26(7):995-1000.
169. Pawelec G., Larbi A., Derhovanessian E. Senescence of the human immune system. Journal of Comparative Pathology 2010, 142(Suppl. 1):S39-S44.
170. Pearson K.J., Baur J.A., Lewis K.N., Peshkin L., Price N.L., Labinskyy N., et al. Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span. Cell Metabolism 2008, 8(2):157-168.
171. Pletcher S.D., Macdonald S.J., Marguerie R., Certa U., Stearns S.C., Goldstein D.B., et al. Genome-wide transcript profiles in aging and calorically restricted Drosophila melanogaster. Current Biology 2002, 12(9):712-723.
172. Poirier J. Apolipoprotein E represents a potent gene-based therapeutic target for the treatment of sporadic Alzheimer's disease. Alzheimer's and Dementia 2008, 4(1, Suppl. 1):S91-S97.
173. Pope C.A., Burnett R.T., Krewski D., Jerrett M., Shi Y., Calle E.E., et al. Cardiovascular mortality and exposure to airborne fine particulate matter and cigarette smoke: Shape of the exposure-response relationship. Circulation 2009, 120(11):941-948.
174. Qin W., Chachich M., Lane M., Roth G., Bryant M., de Cabo R., et al. Calorie restriction attenuates Alzheimer's disease type brain amyloidosis in squirrel monkeys (Saimiri sciureus). Journal of Alzheimer's Disease 2006, 10(4):417-422.
175. Qin W., Yang T., Ho L., Zhao Z., Wang J., Chen L., et al. Neuronal SIRT1 activation as a novel mechanism underlying the prevention of Alzheimer disease amyloid neuropathology by calorie restriction. Journal of Biological Chemistry 2006, 281(31):21745-21754.
176. Rae M.J., Butler R.N., Campisi J., de Grey A.D.N.J., Finch C.E., Gough M., et al. The demographic and biomedical case for late-life interventions in aging. Science Translational Medicine 2010, (in press).
177. Raffai R.L., Dong L.M., Farese R.V., Weisgraber K.H. Introduction of human apolipoprotein E4 "domain interaction" into mouse apolipoprotein E. Proceedings of the National Academy of Sciences of the United States of America 2001, 98(20):11587-11591.
178. Ranjan P., Bowzard J.B., Schwerzmann J.W., Jeisy-Scott V., Fujita T., Sambhara S. Cytoplasmic nucleic acid sensors in antiviral immunity. Trends in Molecular Medicine 2009, 15(8):359-368.
179. Redinger R.N. Fat storage and the biology of energy expenditure. Translational Research 2009, 154(2):52-60.
180. Ridker P.M. Testing the inflammatory hypothesis of atherothrombosis: Scientific rationale for the Cardiovascular Inflammation Reduction Trial (CIRT). Journal of Thrombosis and Haemostasis 2009, 7(Suppl. 1):332-339.
181. Ridker P.M., Danielson E., Fonseca F.A., Genest J., Gotto A.M., Kastelein J.J., JUPITER Trial Study Group, et al. Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: A prospective study of the JUPITER trial. Lancet 2009, 373(9670):1175-1182.
182. Riggs B.L., Melton L.J., Robb R.A., Camp J.J., Atkinson E.J., McDaniel L., et al. A population-based assessment of rates of bone loss at multiple skeletal sites: Evidence for substantial trabecular bone loss in young adult women and men. Journal of Bone and Mineral Research 2008, 23(2):205-214.
183. Rodier F., Coppé J.P., Patil C.K., Hoeijmakers W.A., Muñoz D.P., Raza S.R., et al. Persistent DNA damage signaling triggers senescence-associated inflammatory cytokine secretion. Nature Cell Biology 2009, 11(8):973-979.
184. Roses A.D., Saunders A.M., Huang Y., Strum J., Weisgraber K.H., Mahley R.W. Complex disease-associated pharmacogenetics: Drug efficacy, drug safety, and confirmation of a pathogenetic hypothesis (Alzheimer's disease). Pharmacogenomics Journal 2007, 7(1):10-28.
185. Ross R. Atherosclerosis is an inflammatory disease. American Heart Journal 1999, 138(5, Pt. 2):S419-S420.
186. Rozovsky I., Morgan T.E., Willoughby D.A., Dugichi-Djordjevich M.M., Pasinetti G.M., Johnson S.A., et al. Selective expression of clusterin (SGP-2) and complement C1qB and C4 during responses to neurotoxins in vivo and in vitro. Neuroscience 1994, 62(3):741-758.
187. Russell E.S. Lifespan and aging patterns. The biology of the laboratory mouse 1966, 511-520. McGraw-Hill, New York. E.L. Green (Ed.).
188. Salas-Salvadó J., Bulló M., García-Lorda P., Figueredo R., Del Castillo D., Bonada A., et al. Subcutaneous adipose tissue cytokine production is not responsible for the restoration of systemic inflammation markers during weight loss. International Journal of Obesity 2006, 30(12):1714-1720.
189. Salpea K.D., Talmud P.J., Cooper J.A., Maubaret C.G., Stephens J.W., Abelak K., et al. Association of telomere length with type 2 diabetes, oxidative stress and UCP2 gene variation. Atherosclerosis 2010, 209(1):42-50.
190. Salvioli S., Capri M., Bucci L., Lanni C., Racchi M., Uberti D., et al. Why do centenarians escape or postpone cancer? The role of IGF-1, inflammation and p53. Cancer Immunology, Immunotherapy 2009, 58(12):1909-1917.
191. Sasaki H., Yamamoto H., Tominaga K., Masuda K., Kawai T., Teshima-Kondo S., et al. Receptor activator of nuclear factor-κB ligand-induced mouse osteoclast differentiation is associated with switching between NADPH oxidase homologues. Free Radical Biology & Medicine 2009, 47(2):189-199.
192. Sattar N., Murray H.M., Welsh P., Blauw G.J., Buckley B.M., Cobbe S., et al. Prospective study of pravastatin in the Elderly at Risk (PROSPER) study group: Are markers of inflammation more strongly associated with risk for fatal than for nonfatal vascular events?. PLoS Medicine 2009, 6(6):e1000099.
193. Schächter F., Faure-Delanef L., Guénot F., Rouger H., Froguel P., Lesueur-Ginot L., Cohen D. Genetic associations with human longevity at the APOE and ACE loci. Nature Genetics 1994, 6(1):29-32.
194. Schröder A.K., Rink L. Neutrophil immunity of the elderly. Mechanisms of Ageing and Development 2003, 124(4):419-425.
195. Schumacher B., van der Pluijm I., Moorhouse M.J., Kosteas T., Robinson A.R., Suh Y., et al. Delayed and accelerated aging share common longevity assurance mechanisms. PLoS Genetics 2008, 4(8):e100016.
196. Sierra A., Gottfried-Blackmore A.C., McEwen B.S., Bulloch K. Microglia derived from aging mice exhibit an altered inflammatory profile. Glia 2007, 55(4):412-424.
197. Soscia S.J., Kirby J.E., Washicosky K.J., Tucker S.M., Ingelsson M., Hyman B., et al. The Alzheimer's disease-associated amyloid β-protein is an antimicrobial peptide. PLoS ONE 2010, 5(3):e9505.
198. Sparkman N.L., Johnson R.W. Neuroinflammation associated with aging sensitizes the brain to the effects of infection or stress. Neuroimmunomodulation 2008, 15(4-6):323-330.
199. Spyridopoulos I., Hoffmann J., Aicher A., Brümmendorf T.H., Doerr H.W., Zeiher A.M., et al. Accelerated telomere shortening in leukocyte subpöpulations of patients with coronary heart disease: Role of cytomegalovirus seropositivity. Circulation 2009, 120(14):1364-1372.
200. Stephens J.W., Bain S.C., Humphries S.E. Gene-environment interaction and oxidative stress in cardiovascular disease. Atherosclerosis 2008, 200(2):229-238.
201. Suh Y., Atzmon G., Cho M.O., Hwang D., Liu B., Leahy D.J., et al. Functionally significant insulin-like growth factor I receptor mutations in centenarians. Proceedings of the National Academy of Sciences of the United States of America 2008, 105(9):3438-3442.
202. Sulaiman M., Matta M.J., Sunderesan N.R., Gupta M.P., Periasamy M., Gupta M. Resveratrol, an activator of SIRT1, upregulates sarcoplasmic calcium ATPase and improves cardiac function in diabetic cardiomyopathy. American Journal of Physiology: Heart and Circulatory Physiology 2010, 298(3):H833-H843.
203. Swindell W.R. Genes and gene expression modules associated with caloric restriction and aging in the laboratory mouse. BMC Genomics 2009, 10:585.
204. Szalai A.J., Briles D.E., Volanakis J.E. Human C-reactive protein is protective against fatal Streptococcus pneumoniae infection in transgenic mice. Journal of Immunology 1995, 155(5):2557-2563.
205. Tan K.T., Lip G.Y. Imaging of the unstable plaque. International Journal of Cardiology 2008, 127(2):157-165.
206. Tang Q.O., Tran G.T., Gamie Z., Graham S., Tsialogiannis E., Tsiridis E., et al. Statins: Under investigation for increasing bone mineral density and augmenting fracture healing. Expert Opinion on Investigational Drugs 2008, 17(10):1435-1463.
207. Tegnér J., Nilsson R., Bajic V.B., Björkegren J., Ravasi T. Systems biology of innate immunity. Cell Immunology 2006, 244(2):105-109.
208. Toutouzas K., Synetos A., Stefanadi E., Vaina S., Markou V., Vavuranakis M., et al. Correlation between morphologic characteristics and local temperature differences in culprit lesions of patients with symptomatic coronary artery disease. Journal of the American College of Cardiology 2007, 49(23):2264-2271.
209. Troemel E.R., Chu S.W., Reinke V., Lee S.S., Ausubel F.M., Kim D.H. p38 MAPK regulates expression of immune response genes and contributes to longevity in C. elegans. PLoS Genetics 2006, 2(11):e183.
210. Trzonkowski P., Myśliwska J., Szmit E., Wieckiewicz J., Lukaszuk K., Brydak L.B., et al. Association between cytomegalovirus infection, enhanced proinflammatory response and low level of anti-hemagglutinins during the anti-influenza vaccination-an impact of immunosenescence. Vaccine 2003, 21(25-26):3826-3836.
211. Tukhovskaya E.A., Yukin A.Y., Khokhlova O.N., Murashev A.N., Vitek M.P. COG1410, a novel apolipoprotein-E mimetic, improves functional and morphological recovery in a rat model of focal brain ischemia. Journal of Neuroscience Research 2009, 87(3):677-682.
212. Ulrich P., Cerami A. Protein glycation, diabetes, and aging. Recent Progress in Hormone Research 2001, 56:1-21.
213. Uribarri J., Cai W., Peppa M., Goodman S., Ferrucci L., Striker G., et al. Circulating glycotoxins and dietary advanced glycation endproducts: Two links to inflammatory response, oxidative stress, and aging. Journals of Gerontology, Series A, Biological Sciences and Medical Sciences 2007, 62(4):427-433.
214. Vance R.E., Isberg R.R., Portnoy D.A. Patterns of pathogenesis: Discrimination of pathogenic and nonpathogenic microbes by the innate immune system. Cell Host & Microbe 2009, 6(1):10-21.
215. Van De Parre T.J., Martinet W., Verheye S., Kockx M.M., Van Langenhove G., Herman A.G., et al. Mitochondrial uncoupling protein 2 mediates temperature heterogeneity in atherosclerotic plaques. Cardiovascular Research 2008, 77(2):425-431.
216. van Exel E., Eikelenboom P., Comijs H., Frölich M., Smit J.H., Stek M.L., et al. Vascular factors and markers of inflammation in offspring with a parental history of late-onset Alzheimer disease. Archives of General Psychiatry 2009, 66(11):1263-1270.
217. Virchow, R. (1858). A more precise account of fatty metamorphosis. In Cellular pathologie, lecture XVI (2nd ed., pp. 383-408) (F. Chance, Trans. 1860); from Langheinrich & Bohle (2005), cited above.
218. Vitek M.P., Brown C.M., Colton C.A. APOE genotype-specific differences in the innate immune response. Neurobiology of Aging 2007, 30(9):1350-1360.
219. Vlassara H., Cai W., Goodman S., Pyzik R., Yong A., Chen X., et al. Protection against loss of innate defenses in adulthood by low advanced glycation end products (AGE) intake: Role of the antiinflammatory AGE receptor-1. Journal of Clinical Endocrinology and Metabolism 2009, 94(11):4483-4491.
220. Vodovotz Y., Constantine G., Faeder J., Mi Q., Rubin J., Bartels J., et al. Translational systems approaches to the biology of inflammation and healing. Immunopharmacology and Immunotoxicology 2010.
221. Walston J.D., Matteini A.M., Nievergelt C., Lange L.A., Fallin D.M., Barzilai N., et al. Inflammation and stress-related candidate genes, plasma interleukin-6 levels, and longevity in older adults. Experimental Gerontology 2009, 44(5):350-355.
222. Wang J., He D., Zhang Q., Han Y., Jin S., Qi F. Resveratrol protects against cisplatin-induced cardiotoxicity by alleviating oxidative damage. Cancer Biotherapy & Radiopharmaceuticals 2009, 24(6):675-680.
223. Wang J., Ho L., Qin W., Rocher A.B., Seror I., Humala N., et al. Caloric restriction attenuates beta-amyloid neuropathology in a mouse model of Alzheimer's disease. Federation of American Societies for Experimental Biology Journal 2005, 19(6):659-661.
224. Wang M., Fu Z., Zhang J., Wu J., Jiang L., Khazan B., et al. Milk fat globule-EGF-factor 8 (MFG-E8): A novel protein orchestrator of inflammatory vascular smooth muscle cell proliferation and invasion. Circulation Research 2009, 104(12):1337-1346.
225. Waterlow J.C. Protein turnover with special reference to man. Quarterly Journal of Experimental Physiology and Cognate Medical Sciences 1984, 69(3):409-438.
226. Wigle D.T., Arbuckle T.E., Turner M.C., Bérubé A., Yang Q., Liu S., et al. Epidemiologic evidence of relationships between reproductive and child health outcomes and environmental chemical contaminants. Journal of Toxicology and Environmental Health, Part B, Critical Reviews 2008, 11(5-6):373-517.
227. Winsloe C., Earl S., Dennison E.M., Cooper C., Harvey N.C. Early life factors in the pathogenesis of osteoporosis. Current Osteoporosis Reports 2009, 7(4):140-144.
228. Woods J.A., Vieira V.J., Keylock K.T. Exercise, inflammation, and innate immunity. Immunology and Allergy Clinics of North America 2009, 29(2):381-393.
229. Wozniak M.A., Itzhaki R.F., Faragher E.B., James M.W., Ryder S.D., Irving W.L., Trent Hepatitis C Study Group Apolipoprotein E-epsilon 4 protects against severe liver disease caused by hepatitis C virus. Hepatology 2002, 36(2):456-463.
230. Wu Y., El Shikh M.E., El Sayed R.M., Best A.M., Szakal A.K., Tew J.G. IL-6 produced by immune complex-activated follicular dendritic cells promotes germinal center reactions, IgG responses and somatic hypermutation. International Immunology 2009, 21(6):745-756.
231. Xie Z., Morgan T.E., Rozovsky I., Finch C.E. Aging and glial responses to lipopolysaccharide in vitro: Greater induction of IL-1 and IL-6, but smaller induction of neurotoxicity. Experimental Neurology 2003, 182(1):135-141.
232. Yan S.F., D'Agati V., Schmidt A.M., Ramasamy R. Receptor for advanced glycation endproducts (RAGE): A formidable force in the pathogenesis of the cardiovascular complications of diabetes & aging. Current Molecular Medicine 2007, 7(8):699-710.
233. Yashin A.I., Arbeev K.G., Akushevich I., Ukraintseva S.V., Kulminski A., Arbeeva L.S., et al. Exceptional survivors have lower age trajectories of blood glucose: Lessons from longitudinal data. Biogerontology 2010.
234. Yashin A.I., Ukraintseva S.V., Arbeev K.G., Akushevich I., Arbeeva L.S., Kulminski A.M. Maintaining physiological state for exceptional survival: What is the normal level of blood glucose and does it change with age?. Mechanisms of Ageing and Development 2009, 130(9):611-618.
235. Yasojima K., Schwab C., McGeer E.G., McGeer P.L. Human neurons generate C-reactive protein and amyloid P: Upregulation in Alzheimer's disease. Brain Research 2000, 887(1):80-89.
236. Zak D.E., Aderem A. A systems view of host defense. Nature Biotechnology 2009, 27(11):999-1001.
237. Zanjani H., Finch C.E., Kemper C., Atkinson J., McKeel D., Morris J.C., et al. Complement activation in very early Alzheimer disease. Alzheimer Disease and Associated Disorders 2005, 19(2):55-66.
238. Zhao Z., Zhao C., Zhang X.H., Zheng F., Cai W., Vlassara H., et al. Advanced glycation end products inhibit glucose-stimulated insulin secretion through nitric oxide-dependent inhibition of cytochrome c oxidase and adenosine triphosphate synthesis. Endocrinology 2009, 150(6):2569-2576.